EULAR® 2024 Insights

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

EULAR® 2024 Insights

Rheumatoid Arthritis
SLE
Osteoarthritis
Spondyloarthropathies
Crystal Arthropathies
Osteoporosis
Systemic and Connective Tissue Disease
Vasculitis
All Rheumatology

Playback speed

10 seconds

EULAR® 2024 Insights - Deciphering the Clinical Quandary: A Cross-Sectional Study on the Prevalence and Attributes of Difficult-to-Treat Rheumatoid Arthritis

By EULAR® 2024 Insights FEATURING Hajar Elhani

121 views

June 19, 2024

Comments 0

Rheumatoid Arthritis

Understanding the Psychosocial Determinants of Effective Disease Man…

EULAR® 2024 Insights

M. Dey, E. Nikiphorou

102 views

EULAR® 2024 Insights: EULAR Recommendations Regarding Lifestyle Beha…

EULAR® 2024 Insights

S. Verstappen

68 views

EULAR® 2024 Insights - Challenging the Difficult-to-Treat Rheumatoid…

EULAR® 2024 Insights

L. Šenolt

89 views

EULAR® 2024 Insights: BiTEing RA & Immunosuppressants for Infections…

EULAR® 2024 Insights

D. Van Der Woude

100 views

Difficult-to-Treat Rheumatoid Arthritis

EULAR® 2024 Insights

J. Van Laar

274 views

EULAR® 2024 Insights - Women with RA and Menopause: Results of an NR…

EULAR® 2024 Insights

S. Petford

7 views

EULAR® 2024 Insights: Machine Learning to Characterize Bone Biomarke…

EULAR® 2024 Insights

G. Adami

56 views

EULAR® 2024 Insights - Deciphering the Clinical Quandary: A Cross-Se…

EULAR® 2024 Insights

H. Elhani

121 views

EULAR® 2024 Insights - Interception of the Development of RA by a 1-…

EULAR® 2024 Insights

Q. Dumoulin

83 views